Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Neoplasms 3Motor Activity 2Uterine Neoplasms 1Urinary Bladder Neoplasms 1Smoking Cessation 1Smoking 1Skin Neoplasms 1Neurocognitive Disorders 1Multiple Endocrine Neoplasia Type 1 1Leukemia 1Kidney Neoplasms 1Hematologic Neoplasms 1Graft vs Host Disease 1Endometrial Neoplasms 1Depression 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Colorectal Neoplasms 1Colonic Neoplasms 1Cognitive Dysfunction 1Chronic Disease 1Breast Carcinoma In Situ 1

Interventions

Cyclophosphamide 64Tacrolimus 55Methotrexate 46Mycophenolic Acid 39Cyclosporine 37fludarabine phosphate 35Busulfan 35Antilymphocyte Serum 32fludarabine 29Sirolimus 26Melphalan 23Peripheral Blood Stem Cell Transplantation 22Radiotherapy 21Methylprednisolone 21Whole-Body Irradiation 19Filgrastim 17thymoglobulin 14Thiotepa 11Stem Cell Transplantation 10Rituximab 10ruxolitinib 9Granulocyte Colony-Stimulating Factor 9Prednisone 7Hematopoietic Stem Cell Transplantation 7Etoposide 7Cord Blood Stem Cell Transplantation 7Alemtuzumab 7Transplantation 6Pentostatin 6Cytarabine 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Graft vs Host Disease × Health × Clear all
NCT02976558 2019-12-18

TriCAM

University of Erlangen-Nürnberg Medical School

Phase NA Terminated
104 enrolled
Other hematologic neoplasm

Depression, Graft vs Host Disease, Leukemia, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡